Sökning: onr:"swepub:oai:DiVA.org:uu-15630" >
Pharmacological pro...
Pharmacological profiling of novel non-COX-inhibiting indole-pyran analogues of etodolac reveals high solid tumour activity of SDX-308 in vitro
-
- Lindhagen, Elin (författare)
- Uppsala universitet,Institutionen för medicinska vetenskaper,Cancer Pharmacology and Informatics
-
- Rickardson, Linda (författare)
- Uppsala universitet,Institutionen för medicinska vetenskaper,Cancer Pharmacology and Informatics
-
Elliott, Gary (författare)
-
visa fler...
-
Leoni, Lorenzo (författare)
-
- Nygren, Peter (författare)
- Uppsala universitet,Institutionen för onkologi, radiologi och klinisk immunologi,Cancer Pharmacology and Informatics
-
- Larsson, Rolf (författare)
- Uppsala universitet,Institutionen för medicinska vetenskaper,Cancer Pharmacolcogy and Informatics
-
- Åleskog, Anna (författare)
- Uppsala universitet,Institutionen för medicinska vetenskaper
-
visa färre...
-
(creator_code:org_t)
- 2007-04-18
- 2007
- Engelska.
-
Ingår i: Investigational new drugs. - : Springer Science and Business Media LLC. - 0167-6997 .- 1573-0646. ; 25:4, s. 297-303
- Relaterad länk:
-
http://www.ncbi.nlm....
-
visa fler...
-
https://urn.kb.se/re...
-
https://doi.org/10.1...
-
visa färre...
Abstract
Ämnesord
Stäng
- SDX-308 and SDX-309 are potent indole-pyran analogues of SDX-101 (R-etodolac) which has anti-tumour activity unrelated to cyclooxygenase-2 inhibition. Their cytotoxic activity was further studied herein using a well-characterized human tumour cell-line panel containing ten cell lines, as well as in 58 primary tumour cell samples from a variety of diagnoses. The indole-pyran analogues of SDX-101 were in general considerably more active in both cancer cell lines and primary tumour samples. Low cross-reactivity with standard agents was observed, indicating a unique mechanism of action. No apparent influence on efficacy was observed via classical mechanisms of multidrug-resistance. SDX-101 and SDX-309 showed higher relative activity in haematological compared to solid tumour samples, while SDX-308 had pronounced solid-tumour activity. High SDX-308 cytotoxic efficacy was observed in non-small cell lung cancer, renal cancer and ovarian cancer samples, and also in chronic lymphocytic leukaemia. In conclusion, the indole-pyran analogues showed a favourable pharmacological profile and represent a potentially important new class of drugs for cancer treatment.
Nyckelord
- Antineoplastic Agents/*pharmacology
- Cell Line; Tumor
- Drug Screening Assays; Antitumor
- Etodolac/*analogs & derivatives/*pharmacology
- Female
- Heterocyclic Compounds; 3-Ring/*pharmacology
- Humans
- MEDICINE
- MEDICIN
Publikations- och innehållstyp
- ref (ämneskategori)
- art (ämneskategori)
Hitta via bibliotek
Till lärosätets databas